Submitted by Anonymous (not verified) on 11 September 2025 - 16:00
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 20, Status: Authorised